Furthermore, ALPS is the only autoimmune syndrome in which a germline mutation on one TNFRSF6 allele (72%) and a somatic mutation on the other (0.5%) leads to disease onset; this explains the observed clinical differences between carriers of heterozygous germline mutations. This evidence concerns the gene FAS and autoimmune lymphoproliferative syndrome.